The U-M Board of Regents has appointed Taubman Scholar Henry L. Paulson, MD, PhD, as interim director of the Michigan Neuroscience Institute (MNI), effective March 1, The MNI, which evolved from the Molecular and Behavioral Neuroscience Institute in the Medical School, was approved by regents in January 2020 to engage researchers from multiple disciplines and…
Taubman Emerging Scholar Srijan Sen, MD, PhD, has been appointed as the director of the U-M Depression Center. Dr. Sen, who was awarded a Taubman Emerging Scholar grant in 2014, is a psychiatrist and neuroscientist who has led efforts to understand the role of stress, sleep and genetics in the risk of depression and suicide.…
The Taubman Institute congratulates Sung Won Choi, MD, MS for being chosen as a member of the 2021 class of the American Society for Clinical Investigation (ASCI). She becomes the 90th Michigan Medicine physician-researcher in the society’s current membership roster. Dr. Choi is the Edith S. Briskin and Shirley K. Schlafer Foundation Research Professor, an…
Join David Pinsky, MD, one of Taubman Institute’s founding scholars, and his colleagues at the Frankel Cardiovascular Center when they present, “Follow Your Heart to Better Health,” Thursday, Feb. 11 at 1 pm as part of the Office of Medical Development’s Well Aware with Michigan Medicine lecture series. Dr. Pinsky is the J. Griswold…
Senior Taubman Scholar Henry Paulson and Taubman Emerging Scholar Sami Barmada are cited as experts in a recent ESPN article about a rare neurological disease. Five-year-old Morgan, the child of a Detroit Lions executive, is living with a rare, incurable neurological disease, beta-propeller protein-associated neurodegeneration, known as BPAN. Read the story here. The parents of…
Research from U-M faculty: Yu (Ray) Zuo, MD, Jason Knight, MD, PhD and Yogendra Kanthi, MD, describing abnormal blood clotting in some COVID-19 patients was recently published in the journal, Science Translational Medicine. Their findings are also featured in the TIME magazine article, “Scientists Have Uncovered the Likely Cause of a Serious COVID-19 Symptom: Blood…
COVID-19 has generated a public health crisis that affects every household. And it’s exacerbating another widespread public health crisis that already was ongoing when the pandemic arrived: addiction and other mental health problems. During the pandemic, complications from substance use, and overdose deaths, have been increasing even faster than before. At the same time, it…
Emerging Scholar Sami Barmada, MD, PhD, has invited Dena Dubal, MD, PhD, to speak at Michigan Medicine’s Neurology/Neuroscience seminar Friday, September 25 at Noon-1 pm via Zoom. Dr. Dubal’s presentation is titled, “Mechanisms of Sex Bias in Alzheimer’s Disease: X Marks the Spot.” Whether sex chromosomes contribute to sex difference in Alzheimer’s disease (AD) is…
Earlier, less intrusive and less costly tests for Alzheimer’s disease would allow doctors to try intervention therapies earlier in the disorder’s development, in hopes of slowing or curbing progression of the disease. Taubman Scholar Henry Paulson, MD, PhD, was interviewed recently about some new blood tests making the news among dementia researchers. Read what he…
Join Michigan Medicine’s Daniel Goldstein, MD and renowned human transplantation immunology researchers October 12 at 9 am-Noon for an update on their Taubman Institute Innovation Project (TIIP) that aims to refine the use of immune-suppression drugs in solid organ transplant patients. Dr. Goldstein heads a team of three Michigan Medicine primary investigators in this TIIP,…